Aggregated myocilin induces Russell bodies and causes apoptosis: Implications for the pathogenesis of myocilin-caused primary open-angle glaucoma

American Journal of Pathology

Volumn 170, Issue 1, 2007, Pages 100-109

  Yam, Gary Hin Fai ^a,b   Gaplovska Kysela, Katarina ^a   Zuber, Christian ^a   Roth, Jürgen ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 12; CASPASE 3; INITIATION FACTOR 2; MYOCILIN; CYTOSKELETON PROTEIN; EYE PROTEIN; GLYCOPROTEIN; TRABECULAR MESHWORK-INDUCED GLUCOCORTICOID RESPONSE PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; AQUEOUS HUMOR; ARTICLE; CELL AGGREGATION; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; INTRAOCULAR PRESSURE; NONHUMAN; OPEN ANGLE GLAUCOMA; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; CELL INCLUSION; CHEMISTRY; CHO CELL; CRICETULUS; GENETICS; HAMSTER; METABOLISM; MUTATION; PATHOLOGY; PROTEIN FOLDING;

ANIMALS; APOPTOSIS; CHO CELLS; CRICETINAE; CRICETULUS; CYTOSKELETAL PROTEINS; ENDOPLASMIC RETICULUM; EYE PROTEINS; GLAUCOMA, OPEN-ANGLE; GLYCOPROTEINS; HUMANS; INCLUSION BODIES; INTRAOCULAR PRESSURE; MUTATION; PROTEIN FOLDING;

EID: 33847045670     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.060806     Document Type: Article

References (87)

1. Shields MB, Ritch R, Krupin T: Classification of the Glaucoma. Edited by R Ritch, MB Shields, T Krupin. Philadelphia, Mosby, 1996, pp 717-725
2. Quigley HA: Number of people with glaucoma worldwide. Br J Ophthalmol 1996, 80:389-393
3. Tamm ER: Myocilin and glaucoma: facts and ideas. Prog Retin Eye Res 2002, 21:395-428
4. Tan JC, Peters DM, Kaufman PL: Recent developments in understanding the pathophysiology of elevated intraocular pressure. Curr Opin Ophthalmol 2006, 17:168-174
5. Grierson I, Hogg P: The proliferative and migratory activities of trabecular meshwork cells. Prog Retin Eye Res 1995, 15:33-67
6. Acott TS, Westcott M, Passo MS, van Buskirk EM: Trabecular meshwork glycosaminoglycans in human and cynomolgus monkey eye. Invest Ophthalmol Vis Sci 1985, 26:1320-1329
7. Buller C, Johnson DH, Tschumper RC: Human trabecular meshwork phagocytosis. Observations in an organ culture system. Invest Ophthalmol Vis Sci 1990, 31:2156-2163
8. Rao PV, Deng P, Maddala R, Epstein DL, Li CY, Shimokawa H: Expression of dominant negative Rho-binding domain of Rho-kinase in organ cultured human eye anterior segments increases aqueous humor outflow. Mol Vis 2005, 11:288-297
9. Santas AJ, Bahler C, Peterson JA, Filla MS, Kaufman PL, Tamm ER, Johnson DH, Peters DM: Effect of heparin II domain of fibronectin on aqueous outflow in cultured anterior segments of human eyes. Invest Ophthalmol Vis Sci 2003, 44:4796-4804
10. Clark AF, Brotchie D, Read AT, Hellberg P, English-Wright S, Pang IH, Ethier CR, Grierson I: Dexamethasone alters F-actin architecture and promotes cross-linked actin network formation in human trabecular meshwork tissues. Cell Motil Cytoskeleton 2005, 60:83-95
11. Stone EM, Fingert JH, Alward LM, Nguyen TD, Polansky JR, Sunden SL, Nishimura D, Clark AF, Nystuen A, Nichols BE, Mackey DA, Ritch R, Kalenak JW: Identification of a gene that causes primary open angle glaucoma. Science 1997, 275:668-670
12. Alward WL, Fingert JH, Coote MA, Johnson AT, Lerner SF, Junqua D, Durcan FJ, McCartney PJ, Mackey DA, Sheffield VC, Stone EM: Clinical features associated with mutations in the chromosome 1 open-angle glaucoma gene (GLC1A). N Engl J Med 1998, 338:1022-1027
13. Swiderski RE, Ross JL, Fingert JH, Clark AF, Alward WL, Stone EM, Sheffield VC: Localization of MYOC transcripts in human eye and optic nerve by in situ hybridization. Invest Ophthalmol Vis Sci 2000, 41:3420-3428
14. Huang W, Jaroszewski J, Ortego J, Escribano J, Coca-Prados M: Expression of the TIGR gene in the iris, ciliary body, and trabecular meshwork of the human eye. Ophthalmic Genet 2000, 21:155-169
15. Karali A, Russell P, Stefani F, Tamm E: Localization of myocilin/trabecular meshwork-inducible glucocorticoid response protein in the human eye. Invest Ophthalmol Vis Sci 2000, 41:729-740
16. Tamm ER, Polansky JR: The TIGR/MYOC gene and glaucoma: opportunities for new understandings. J Glaucoma 2001, 10:S9-S12
17. Ueda J, Wentz-Hunter K, Yue BY: Distribution of myocilin and extracellular matrix components in the juxtacanalicular tissue of human eyes. Invest Ophthalmol Vis Sci 2002, 43:1068-1076
18. Fautsch MP, Vrabel AM, Johnson DH: The identification of myocilin-associated proteins in the human trabecular meshwork. Exp Eye Res 2006, 82:1046-1052
19. Gobeil S, Letartre L, Raymond V: Functional analysis of the glaucoma-causing TIGR/myocilin protein: integrity of amino-terminal coiled-coil regions and olfactomedin homology domain is essential for extracellular adhesion and secretion. Exp Eye Res 2006, 82:1017-1029
20. Whitmore AV, Libby RT, John SW: Glaucoma: thinking in new ways - a role for autonomous axonal self-destruction and other compartmentalized processes? Prog Retin Eye Res 2005, 24:639-662
21. Kim BS, Savinova OV, Reedy MV, Martin J, Lun Y, Gan L, Smith RS, Tomarev SI, John SW, Johnson RL: Targeted disruption of the myocilin gene (Myoc) suggests that human glaucoma-causing mutations are gain of function. Mol Cell Biol 2001, 21:7707-7713
22. Gould DB, Miceli-Libby L, Savinova OV, Torrado M, Tomarev SI, Smith RS, John SWM: Genetically increasing Myoc expression supports a necessary pathologic role of abnormal proteins in glaucoma. Mol Cell Biol 2004, 24:9019-9025
23. Zhou Z, Vollrath D: A cellular assay distinguishes normal and mutant TIGR/myocilin protein. Hum Mol Genet 1999, 8:2221-2228
24. Jacobson N, Andrews M, Shepard AR, Nishimura D, Searby C, Fingert JH, Hageman G, Mullins R, Davidson BL, Kwon YH, Alward WL, Stone EM, Clark AF, Sheffield VC: Non-secretion of mutant proteins of the glaucoma gene myocilin in cultured trabecular meshwork cells and in aqueous humor. Hum Mol Genet 2001, 10:117-125
25. Joe MK, Sohn S, Hur W, Moon Y, Choi YR, Kee C: Accumulation of mutant myocilins in ER leads to ER stress and potential cytotoxicity in human trabecular meshwork cells. Biochem Biophys Res Commun 2003, 312:592-600
26. Liu Y, Vollrath D: Reversal of mutant myocilin non-secretion and cell killing: implications for glaucoma. Hum Mol Genet 2004, 13:1193-1204
27. Vollrath D, Liu YH: Temperature sensitive secretion of mutant myocilins. Exp Eye Res 2006, 82:1030-1036
28. Morissette J, Clepet C, Moisan S, Dubois S, Winstall E, Vermeeren D, Nguyen TD, Polansky JR, Cote G, Anctil JL, Amyot M, Plante M, Falardeau P, Raymond V: Homozygotes carrying an autosomal dominant TIGR mutation do not manifest glaucoma. Nat Genet 1998, 19:319-321
29. Lam DS, Leung YF, Chua JK, Baum L, Fan DS, Choy KW, Pang CP: Truncations in the TIGR gene in individuals with and without primary open-angle glaucoma. Invest Ophthalmol Vis Sci 2000, 41:1386-1391
30. Sohn S, Hur W, Joe MK, Kim JH, Lee ZW, Ha HS, Kee C: Expression of wild-type and truncated myocilins in trabecular meshwork cells: their subcellular localizations and cytotoxicities. Invest Ophthalmol Vis Sci 2002, 43:3680-3685
31. Gobeil S, Rodrigue MA, Moisan S, Nguyen TD, Polansky JR, Morissette J, Raymond V: Intracellular sequestration of hetero-oligomers formed by wild-type and glaucoma-causing myocilin mutants. Invest Ophthalmol Vis Sci 2004, 45:3560-3567
32. Shirato S, Murphy CG, Bloom E, Franse-Carman L, Maglio MT, Polansky JR, Alvarado JA: Kinetics of phagocytosis in trabecular meshwork cells. Flow cytometry and morphometry. Invest Ophthalmol Vis Sci 1989, 30:2499-2511
33. Schlotzer-Schrehardt U, Naumann GO: Trabecular meshwork in pseudoexfoliation syndrome with and without open-angle glaucoma. A morphometric, ultrastructural study. Invest Ophthalmol Vis Sci 1995, 36:1750-1764
34. Matsumoto Y, Johnson DH: Dexamethasone decreases phagocytosis by human trabecular meshwork cells in situ. Invest Ophthalmol Vis Sci 1997, 38:1902-1907
35. Lütjen-Drecoll E, Shimizu T, Rohrbach M, Rohen JW: Quantitative analysis of 'plaque material' in the inner- and outer wall of Schlemm's canal in normal- and glaucomatous eyes. Exp Eye Res 1986, 42:443-455
36. Rohen JW, Lütjen-Drecoll E, Flugel C, Meyer M, Grierson I: Ultrastructure of the trabecular meshwork in untreated cases of primary open-angle glaucoma (POAG). Exp Eye Res 1993, 56:683-692
37. Gottanka J, Flugel-Koch C, Martus P, Johnson DH, Lütjen-Drecoll E: Correlation of pseudoexfoliative material and optic nerve damage in pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci 1997, 38:2435-2446
38. Lütjen-Drecoll E: Functional morphology of the trabecular meshwork in primate eyes. Prog Retin Eye Res 1999, 18:91-119
39. Cracknell KP, Grierson I, Hogg P, Majekodunmi AA, Watson P, Marmion V: Melanin in the trabecular meshwork is associated with age, POAG but not Latanoprost treatment. A masked morphometric study. Exp Eye Res 2006, 82:986-993
40. Alvarado J, Murphy C, Juster R: Trabecular meshwork cellularity in primary open-angle glaucoma and nonglaucomatous normals. Ophthalmology 1984, 91:564-579
41. Polansky JR, Weinreb RN, Baxter JD, Alvarado J: Human trabecular cells. I. Establishment in tissue culture and growth characteristics. Invest Ophthalmol Vis Sci 1979, 18:1043-1049
42. Brown WJ, Farquhar MG: Immunoperoxidase methods for the localization of antigens in cultured cells and tissue sections by electron microscopy. Methods Cell Biol 1989, 31:553-569
43. Yam GHF, Zuber C, Roth J: A synthetic chaperone corrects the trafficking defect and disease phenotype in a protein misfolding disorder. FASEB J 2005, 19:12-18
44. Merits M, Garfield S, Tanemoto K, Tomarev SI: Identification of the region in the N-terminal domain responsible for the cytoplasmic localization of Myoc/Tigr and its association with microtubules. Lab Invest 1999, 79:1237-1245
45. Kopito RR, Sitia R: Aggresomes and Russell bodies. Symptoms of cellular indigestion? EMBO Rep 2000, 1:225-231
46. Pavelka M, Roth J: Functional Ultrastructure: An Atlas of Tissue Biology and Pathology. Wien, Springer Medicine, 2005
47. Raposo G, van Santen HM, Leijendekker R, Geuze HJ, Ploegh HL: Misfolded major histocompatibility complex class I molecules accumulate in an expanded ER-Golgi intermediate compartment. J Cell Biol 1995, 131:1403-1419
48. Gilbert A, Jadot M, Leontieva E, Wattiaux-De Coninck S, Wattiaux R: Delta F508 CFTR localizes in the endoplasmic reticulum-Golgi intermediate compartment in cystic fibrosis cells. Exp Cell Res 1998, 242:144-152
49. Zuber C, Fan JY, Guhl B, Roth J: Misfolded proinsulin accumulates in expanded pre-Golgi intermediates and endoplasmic reticulum subdomains in pancreatic beta cells of Akita mice. FASEB J 2004, 18:917-919
50. Mattioli L, Anelli T, Fagioli C, Tacchetti C, Sitia R, Valetti C: ER storage diseases: a role for ERGIC-53 in controlling the formation and shape of Russell bodies. J Cell Sci 2006, 119:2532-2541
51. Schindler R, Itin C, Zerial M, Lottspeich F, Hauri HP: ERGIC-53, a membrane protein of the ER-Golgi intermediate compartment, carries an ER retention motif. Eur J Cell Biol 1993, 61:1-9
52. Kaufman RJ: Orchestrating the unfolded protein response in health and disease. J Clin Invest 2002, 110:1389-1398
53. Nadanaka S, Yoshida H, Kano F, Murata M, Mori K: Activation of mammalian unfolded protein response is compatible with the quality control system operating in the endoplasmic reticulum. Mol Biol Cell 2004, 15:2537-2548
54. Schroder M, Kaufman RJ: ER stress and the unfolded protein response. Mutat Res 2005, 569:29-63
55. Sommer A, Tielsch JM, Katz J, Quigley HA, Gottsch JD, Javitt J, Singh K: Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch Ophthalmol 1991, 109:1090-1095
56. Shields MB: Textbook of Glaucoma. Baltimore, Williams & Wilkins, 1992
57. Wiggs JL, Allingham RR, Vollrath D, Jones KH, De La Paz M, Kern J, Patterson K, Babb VL, Del Bono EA, Broomer BW, Pericak-Vance MA, Haines JL: Prevalence of mutations in TIGR/myocilin in patients with adult and juvenile primary open-angle glaucoma. Am J Hum Genet 1998, 63:1549-1552
58. Fingert JH, Heon E, Liebmann JM, Yamamoto T, Craig JE, Rait J, Kawase K, Hoh ST, Buys YM, Dickinson J, Hockey RR, Williams-Lyn D, Trope G, Kitazawa Y, Ritch R, Mackey DA, Alward WL, Sheffield VC, Stone EM: Analysis of myocilin mutations in 1703 glaucoma patients from five different populations. Hum Mol Genet 1999, 8:899-905
59. Faucher MP, Anctil JL, Rodrigue MA, Duchesne A, Bergeron D, Blondeau P, Cote G, Dubois S, Bergeron J, Arseneault R, Morissette J, Raymond V, Quebec Glaucoma Network: Founder TIGR/myocilin mutations for glaucoma in the Quebec population. Hum Mol Genet 2002, 11:2077-2090
60. Caballero M, Borras T: Inefficient processing of an olfactomedin- deficient myocilin mutant: potential physiological relevance to glaucoma. Biochem Biophys Res Commun 2001, 282:662-670
61. Adam MF, Belmouden A, Binisti P, Brezin AP, Valtot F, Bechetoille A, Dasootte JC, Copin B, Gomez L, Chaventre A, Bach JF, Garchon HJ: Recurrent mutations in a single exon encoding the evolutionary conserved olfactomedin-homology domain of TIGR in familial open-angle glaucoma. Hum Mol Genet 1997, 6:2091-2097
62. Fan BJ, Leung DYL, Wang DY, Gobeil S, Raymond V, Tam POS, Lam DSC, Pang CP: Novel myocilin mutation in a Chinese family with juvenile-onset open-angle glaucoma. Arch Ophthalmol 2006, 124:102-106
63. Roth J: Protein N-glycosylation along the secretory pathway: relationship to organelle topography and function, protein quality control and cell interactions. Chem Rev 2002, 102:285-303
64. Ellgaard L, Helenius A: Quality control in the endoplasmic reticulum. Nat Rev Mol Cell Biol 2003, 4:181-191
65. Trombetta ES, Parodi AJ: Quality control and protein folding in the secretory pathway. Annu Rev Cell Dev Biol 2003, 19:649-676
66. Sitia R, Braakman I: Quality control in the endoplasmic reticulum protein factory. Nature 2003, 426:891-894
67. Ahner A, Brodsky JL: Checkpoints in ER-associated degradation: excuse me, which way to the proteasome? Trends Cell Biol 2004, 14:474-478
68. Hirsch C, Jarosch E, Sommer T, Wolf DH: Endoplasmic reticulum-associated protein degradation - one model fits all? Biochim Biophys Acta 2004, 1695:208-216
69. Meusser B, Hirsch C, Jarosch E, Sommer T: ERAD: the long road to destruction. Nat Cell Biol 2005, 7:766-772
70. Kim PS, Arvan P: Endocrinopathies in the family of endoplasmic reticulum (ER) storage diseases: disorders of protein trafficking and the role of ER molecular chaperones. Endocr Rev 1998, 19:173-202
71. Aridor M, Hannan LA: Traffic jams II: an update of diseases of intracellular transport. Traffic 2002, 3:781-790
72. Ross CA, Poirier MA: Protein aggregation and neurodegenerative disease. Nat Med 2004, 10:S10-S17
73. Carrell RW: Cell toxicity and conformational disease. Trends Cell Biol 2005, 15:574-580
74. Johnston JA, Ward CL, Kopito RR: Aggresomes: a cellular response to misfolded proteins. J Cell Biol 1998, 143:1883-1898
75. Kopito RR: Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol 2000, 10:524-530
76. Alanen A, Pira U, Lassila O, Roth J, Franklin RM: Mott cells are plasma cells defective in immunoglobulin secretion. Eur J Immunol 1985, 15:235-242
77. Valetti C, Grossi CE, Milstein C, Sitia R: Russell bodies: a general response of secretory cells to synthesis of a mutant immunoglobulin which can neither exit from, nor be degraded in the endoplasmic reticulum. J Cell Biol 1991, 115:983-994
78. Palade GE: Intracisternal granules in the exocrine cells of the pancreas. J Biophys Biochem Cytol 1956, 2:417-422
79. Tooze J, Kern HF, Fuller SD, Howell KE: Condensation-sorting events in the rough endoplasmic reticulum of exocrine pancreatic cells. J Cell Biol 1989, 109:35-50
80. Lomas DA, Evans DL, Finch JT, Carrell RW: The mechanism of Z alpha 1-antitrypsin accumulation in the liver. Nature 1992, 357:605-607
81. Medeiros-Neto G, Kim PS, Yoo SE, Vono J, Targovnik HM, Camargo R, Hossain SA, Arvan P: Congenital hypothyroid goiter with deficient thyroglobulin. Identification of an endoplasmic reticulum storage disease with induction of molecular chaperones. J Clin Invest 1996, 98:2838-2844
82. Hauri HP, Kappeler F, Andersson H, Appenzeller C: ERGIC-53 and traffic in the secretory pathway. J Cell Sci 2000, 113:587-596
83. Hsu VW, Yuan LC, Nuchtern JG, Lippincott-Schwartz J, Hammerling GJ, Klausner RD: A recycling pathway between the endoplasmic reticulum and the Golgi apparatus for retention of unassembled MHC class I molecules. Nature 1991, 352:441-444
84. Lucocq JM, Brada D, Roth J: Immunolocalization of the oligosaccharide trimming enzyme glucosidase II. J Cell Biol 1986, 102:2137-2146
85. Zuber C, Fan JY, Guhl B, Parodi A, Fessler JH, Parker C, Roth J: Immunolocalization of UDP-glucose:glycoprotein glucosyltransferase indicates involvement of pre-Golgi intermediates in protein quality control. Proc Natl Acad Sci USA 2001, 98:10710-10715
86. Taxis C, Vogel F, Wolf DH: ER-Golgi traffic is a prerequisite for efficient ER degradation. Mol Biol Cell 2002, 13:1806-1818
87. Vashist S, Ng DT: Misfolded proteins are sorted by a sequential checkpoint mechanism of ER quality control. J Cell Biol 2004, 165:41-52